RBC Capital Markets – February 24
BTIG – February 25
Barclays – March 16
Credit Suisse – March 16
SOUTH JORDAN, Utah, Feb. 10, 2016 -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will present at four investor conferences in the next few weeks.
On Wednesday, February 24, at 10:30 a.m. ET, Merit’s Chairman and Chief Executive Officer Fred P. Lampropoulos will present and participate in one-on-one meetings at the RBC Capital Markets Healthcare Conference at The New York Palace Hotel in New York City.
On Thursday, February 25, Merit’s Chief Financial Officer Bernard Birkett will participate in one-on-one meetings at BTIG’s Snowbird MedTech Conference in Snowbird, Utah.
On Wednesday, March 16, at 9:30 a.m. ET, Lampropoulos will present and participate in one-on-one meetings at Barclays Global Healthcare Conference at Loews Miami Beach Hotel in Miami Beach, Florida.
On Wednesday, March 16, Birkett will participate in one-on-one meetings at the Credit Suisse Under Followed Opportunities (UFO) Conference at the Credit Suisse offices in Boston.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 200 individuals. Merit employs approximately 3,700 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; and Rockland, Massachusetts.
Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208-4167 e-mail: [email protected] Fax: (801) 253-1688


JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates
Alphabet Replaces Verizon in Dow Jones Industrial Average
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi
Trump’s Quantum Push Lifts IBM Stock as CEO Arvind Krishna Receives White House Praise
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 



